Tecan, Innovatis Ink Co-marketing Plan | GenomeWeb

NEW YORK (GenomeWeb News) – Tecan said today that it will collaborate with Innovatis to jointly market robotic cell culture workstations and cell detection devices.

Under the agreement, the companies will co-market Innovatis' Cellavista automated image-based cellular analysis platform and Tecan's Freedom EVO platform. Used together, Tecan said, the platforms allow automation of a wide range of cell-related processes including cell line development, cell proliferation, stem cell differentiation, and cell-based assays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.